<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">therapeutic</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский журнал терапевтической практики</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Therapeutic Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8156</issn><publisher><publisher-name>РостГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2712-8156-2020-1-2-54-58</article-id><article-id custom-type="elpub" pub-id-type="custom">therapeutic-45</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь длительности сна и кардиометаболических показателей пациентов с сахарным диабетом</article-title><trans-title-group xml:lang="en"><trans-title>The relationship between sleep duration and cardiometabolic parameters in patients with diabetes mellitus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4874-7835</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волкова</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkova</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Волкова Наталья Ивановна, доктор медицинских наук, профессор, проректор по научной работе, заведующий кафедрой внутренних болезней №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Natalya I. Volkova, Dr. Sci. (Med.), Professor, Vice-rector for science, Head of the Department of Internal diseases 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">volkova_n_i@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3002-9595</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джериева</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzherieva</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джериева Ирина Саркисовна, доктор медицинских наук, профессор кафедры внутренних болезней №3 ФГБОУ ВО РостГМУ Минздрава России</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Irina S. Dzherieva, Dr. Sci. (Med.), Professor at the Department of Internal diseases 3, Rostov State Medical University</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">dgerieva@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5135-937X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пляшкевич</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Plyashkevich</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пляшкевич Мария Вадимовна, студентка 6 курса 10 группы лечебно-профилактического факультета</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Maria V. Plyashkevich, 6th year student of the 10th group of the medical and preventive faculty</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">mariya.alaverdova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2486-5223</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бровкина</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Brovkina</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бровкина Снежана Сергеевна, врач-ординатор кафедры внутренних болезней №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Snazhana S. Brovkina, resident of the Department of Internal diseases 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">snegka12345@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7618-5836</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривобокова</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Krivobokova</surname><given-names>T. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кривобокова Татьяна Сергеевна, врач ультразвуковой диагностики</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Tatyana S. Krivobokova, doctor of ultrasound diagnostics</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">krivobokovat@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Rostov State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава России;&#13;
Городской эндокринологический центр МБУЗ «ГБ № 4 г. Ростова-на-Дону»<country>Россия</country></aff><aff xml:lang="en">Rostov State Medical University;&#13;
City Endocrinology Center “City Hospital No. 4 of Rostov-on-Don”<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ГБУ РО «Онкологический диспансер»<country>Россия</country></aff><aff xml:lang="en">«Oncological Dispensary»<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>19</day><month>08</month><year>2020</year></pub-date><volume>1</volume><issue>2</issue><fpage>54</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Волкова Н.И., Джериева И.С., Пляшкевич М.В., Бровкина С.С., Кривобокова Т.С., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Волкова Н.И., Джериева И.С., Пляшкевич М.В., Бровкина С.С., Кривобокова Т.С.</copyright-holder><copyright-holder xml:lang="en">Volkova N.I., Dzherieva I.S., Plyashkevich M.V., Brovkina S.S., Krivobokova T.S.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.therapeutic-j.ru/jour/article/view/45">https://www.therapeutic-j.ru/jour/article/view/45</self-uri><abstract><sec><title>Цель</title><p>Цель: изучить взаимосвязь длительности сна и кардиометаболических показателей пациентов с сахарным диабетом.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: в исследование были включены пациенты с сахарным диабетом типа 1 и типа 2 в отсутствие острой метаболической декомпенсации. Критерии исключения: наличие депрессивного эпизода, алкогольной зависимости, онкологических заболеваний, эритроцитоза, синдрома апноэ сна. Длительность сна определялась по ответам пациентов: менее 6 часов, более 6 часов и до 8 часов, более 8 часов и до 10 часов. Учитывалось выполнение рекомендаций врача по приему гиполипидемических, гипогликемических и гипотензивных препаратов в течение последних 6 месяцев. Статистическая обработка проводилась с применением критерия Колмогорова-Смирнова. Так как выборка была непараметрической, то данные представлены Me (Q25; Q75), где Ме — медиана, Q25 — 25-й процентиль, Q75 — 75-й процентиль, для оценки связи между явлениями был рассчитан коэффициент ранговой корреляции Спирмена.</p></sec><sec><title>Результаты</title><p>Результаты: всего опрошено 92 пациента. Из выборочной совокупности исключены 7 пациентов в связи с выявлением депрессивного эпизода и 4 пациента в связи с алкогольной зависимостью. Таким образом, в исследование включен 81 пациент, из которых 21 пациент с сахарным диабетом 1 типа и 60 пациентов с сахарным диабетом 2 типа. Коэффициент корреляции Спирмена показал, что существует прямая связь между длительностью сна и уровнем HbA1c (p &lt; 0.01).</p></sec><sec><title>Заключение</title><p>Заключение: подтверждена взаимосвязь между уровнем гликированного гемоглобина как показателя компенсации углеводного обмена и длительностью сна.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objectives</title><p>Objectives: to study the relationship between sleep duration and cardiometabolic parameters in patients with diabetes mellitus.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: the study included patients with type 1 and type 2 diabetes mellitus in the absence of acute metabolic decompensation. The exclusion criteria were: the presence of a depressive episode, the presence of alcohol dependence. In addition, the study did not include patients with cancer, erythrocytosis, sleep apnea syndrome. The duration of the patient’s sleep was determined by answering the question: less than 6 hours, more than 6 hours and up to 8 hours inclusive and more than 8 hours and up to 10 hours inclusive. In addition, the patients were questioned about their compliance with the doctor’s recommendation to take hypolipidemic hypoglycemic and antihypertensive drugs during the last 6 months preceding the survey. Statistical data processing was carried out using the Kolmogorov-Smirnov test. Since the sample was nonparametric, the data are presented by Me (Q25; Q75), where Me is the median, Q25 is the 25th percentile, and Q75 is the 75th percentile, and Spearman’s rank correlation coefficient (P) was calculated to assess the relationship between events.</p></sec><sec><title>Results</title><p>Results: a total of 92 patients were interviewed. 7 patients were excluded from the sample due to the identification of a depressive episode and four patients due to the presence of alcohol dependence. Thus, the study included 81 patients, of whom 21 patients were observed for type 1 diabetes mellitus and 60 patients for type 2 diabetes mellitus. Spearman’s correlation coefficient showed that there is a direct relationship between sleep duration and HbA1c level (p &lt; 0.01).</p></sec><sec><title>Conclusion</title><p>Conclusion: in our pilot study, the relationship between the level of glycated hemoglobin as an indicator of compensation for carbohydrate metabolism and sleep duration was confirmed.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>депривация сна</kwd><kwd>сахарный диабет</kwd><kwd>кардиометаболические расстройства</kwd><kwd>факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>sleep deprivation</kwd><kwd>diabetes</kwd><kwd>cardiometabolic disorders</kwd><kwd>risk factors</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>ФГБОУ ВО «Ростовский государственный медицинский университет» МЗ РФ; Ростов-на-Дону, Россия. Городской эндокринологический центр МБУЗ «ГБ №4 г. Ростова-на-Дону»; Ростов-на-Дону, Россия</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med Rev. 2017;31:91- 101. https://doi.org/10.1016/j.smrv.2016.02.001</mixed-citation><mixed-citation xml:lang="en">Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med Rev. 2017;31:91-101. doi:10.1016/j.smrv.2016.02.001</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Reutrakul S, Thakkinstian A, Anothaisintawee T, et al. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med. 2016;23:26-45. https://doi.org/10.1016/j.sleep.2016.03.019</mixed-citation><mixed-citation xml:lang="en">Reutrakul S, Thakkinstian A, Anothaisintawee T, et al. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med. 2016;23:26-45. doi:10.1016/j.sleep.2016.03.019</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kim CE, Shin S, Lee HW, Lim J, Lee JK, Shin A, et al. Association between sleep duration and metabolic syndrome: a cross-sectional study. BMC Public Health. 2018;18(1):720. https://doi.org/10.1186/s12889-018-5557-8</mixed-citation><mixed-citation xml:lang="en">Kim CE, Shin S, Lee HW, et al. Association between sleep duration and metabolic syndrome: a cross-sectional study. BMC Public Health. 2018;18(1):720. Published 2018 Jun 13. doi:10.1186/s12889-018-5557-8</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, et al. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2016;134(18):e367-e386. https://doi.org/10.1161/CIR.0000000000000444</mixed-citation><mixed-citation xml:lang="en">St-Onge MP, Grandner MA, Brown D, et al. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2016;134(18):e367-e386. doi:10.1161/CIR.0000000000000444</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Джериева И.С., Волкова Н.И. Циркадные ритмы и факторы развития сердечно-сосудистых катастроф // Мелатонин: перспективы применения в клинике. Под ред. С.И. Рапопорта. М.: ИМА-ПРЕСС, 2012. – С. 119-124.</mixed-citation><mixed-citation xml:lang="en">Dzherieva I.S., Volkova N.I. Circadian rhythms and factors in the development of cardiovascular catastrophes // Melatonin: prospects for clinical use / ed. S.I. Rapoport. - M .: IMA-PRESS, 2012 .-- S. 119-124.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157(8):549-557. https://doi.org/10.7326/0003-4819-157-8-201210160-00005</mixed-citation><mixed-citation xml:lang="en">Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157(8):549-557. doi:10.7326/0003-4819-157-8-201210160-00005</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ford ES, Wheaton AG, Chapman DP, Li C, Perry GS, Croft JB. Associations between self-reported sleep duration and sleeping disorder with concentrations of fasting and 2-h glucose, insulin, and glycosylated hemoglobin among adults without diagnosed diabetes. J Diabetes. 2014;6(4):338-350. https://doi.org/10.1111/1753-0407.12101</mixed-citation><mixed-citation xml:lang="en">Ford ES, Wheaton AG, Chapman DP, Li C, Perry GS, Croft JB. Associations between self-reported sleep duration and sleeping disorder with concentrations of fasting and 2-h glucose, insulin, and glycosylated hemoglobin among adults without diagnosed diabetes. J Diabetes. 2014;6(4):338-350. doi:10.1111/1753-0407.12101</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rafalson L, Donahue RP, Stranges S, Lamonte MJ, Dmochowski J, Dorn J, et al. Short sleep duration is associated with the development of impaired fasting glucose: the Western New York Health Study. Ann Epidemiol. 2010;20(12):883- 889. https://doi.org/10.1016/j.annepidem.2010.05.002</mixed-citation><mixed-citation xml:lang="en">Rafalson L, Donahue RP, Stranges S, et al. Short sleep duration is associated with the development of impaired fasting glucose: the Western New York Health Study. Ann Epidemiol. 2010;20(12):883-889. doi:10.1016/j.annepidem.2010.05.002</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One. 2009;4(2):e4589. https://doi.org/10.1371/journal.pone.0004589</mixed-citation><mixed-citation xml:lang="en">van Leeuwen WM, Lehto M, Karisola P, et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One. 2009;4(2):e4589. doi:10.1371/journal.pone.0004589</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
